{"title":"基于网络表型策略 (NPS) 计算方法的肝细胞癌患者临床数据分析和预后新方法。","authors":"Brian Carr, Patricia Sotáková, Petr Pancoska","doi":"10.14744/jilti.2024.63935","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>There is a multi-component nature of the influences on HCC progression but integrating them has been difficult. Network phenotyping strategy (NPS) integrates all multi-component relationship facets of HCC progression and aims to lead to a new way of understanding human HCC biology.</p><p><strong>Methods: </strong>We converted baseline patient demographics, tumor characteristics, blood hematology and liver function test results, consisting of values of 17 standard clinical variables, collected time-coherently at the index visit, into a graph-theoretical data representation.</p><p><strong>Results: </strong>These data were analyzed by NPS, which processes the patient parameter values together with their complete relationships network. NPS identified 25 disease-progression ordered HCC phenotypes. Clinically relevant NPS results are a) Portal vein thrombosis incidence during HCC progression stratified into 5 narrow ranges; b) NPS identified patients according to aggressive, slow and intermediate tumor growth sub-types; c) Personalized prognostication of mortality was achieved by the 25 NPS phenotypes, independently optimized for respective phenotype sub-cohorts.</p><p><strong>Conclusion: </strong>The NPS results were implemented as an internet application (https://apkatos.github.io/webpage_nps), where input of 17 clinical parameters provides the patient phenotype, phenotype-characteristic average mortality and personal survival estimate.</p>","PeriodicalId":520497,"journal":{"name":"Journal of Inonu Liver Transplantation Institute","volume":"2 3","pages":"109-116"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11972422/pdf/","citationCount":"0","resultStr":"{\"title\":\"A New Approach to Analysis of Clinical Data and Prognostication for Patients with Hepatocellular Carcinoma, Based Upon a Network Phenotyping Strategy (NPS) Computational Method.\",\"authors\":\"Brian Carr, Patricia Sotáková, Petr Pancoska\",\"doi\":\"10.14744/jilti.2024.63935\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>There is a multi-component nature of the influences on HCC progression but integrating them has been difficult. Network phenotyping strategy (NPS) integrates all multi-component relationship facets of HCC progression and aims to lead to a new way of understanding human HCC biology.</p><p><strong>Methods: </strong>We converted baseline patient demographics, tumor characteristics, blood hematology and liver function test results, consisting of values of 17 standard clinical variables, collected time-coherently at the index visit, into a graph-theoretical data representation.</p><p><strong>Results: </strong>These data were analyzed by NPS, which processes the patient parameter values together with their complete relationships network. NPS identified 25 disease-progression ordered HCC phenotypes. Clinically relevant NPS results are a) Portal vein thrombosis incidence during HCC progression stratified into 5 narrow ranges; b) NPS identified patients according to aggressive, slow and intermediate tumor growth sub-types; c) Personalized prognostication of mortality was achieved by the 25 NPS phenotypes, independently optimized for respective phenotype sub-cohorts.</p><p><strong>Conclusion: </strong>The NPS results were implemented as an internet application (https://apkatos.github.io/webpage_nps), where input of 17 clinical parameters provides the patient phenotype, phenotype-characteristic average mortality and personal survival estimate.</p>\",\"PeriodicalId\":520497,\"journal\":{\"name\":\"Journal of Inonu Liver Transplantation Institute\",\"volume\":\"2 3\",\"pages\":\"109-116\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11972422/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Inonu Liver Transplantation Institute\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.14744/jilti.2024.63935\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Inonu Liver Transplantation Institute","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14744/jilti.2024.63935","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
A New Approach to Analysis of Clinical Data and Prognostication for Patients with Hepatocellular Carcinoma, Based Upon a Network Phenotyping Strategy (NPS) Computational Method.
Objectives: There is a multi-component nature of the influences on HCC progression but integrating them has been difficult. Network phenotyping strategy (NPS) integrates all multi-component relationship facets of HCC progression and aims to lead to a new way of understanding human HCC biology.
Methods: We converted baseline patient demographics, tumor characteristics, blood hematology and liver function test results, consisting of values of 17 standard clinical variables, collected time-coherently at the index visit, into a graph-theoretical data representation.
Results: These data were analyzed by NPS, which processes the patient parameter values together with their complete relationships network. NPS identified 25 disease-progression ordered HCC phenotypes. Clinically relevant NPS results are a) Portal vein thrombosis incidence during HCC progression stratified into 5 narrow ranges; b) NPS identified patients according to aggressive, slow and intermediate tumor growth sub-types; c) Personalized prognostication of mortality was achieved by the 25 NPS phenotypes, independently optimized for respective phenotype sub-cohorts.
Conclusion: The NPS results were implemented as an internet application (https://apkatos.github.io/webpage_nps), where input of 17 clinical parameters provides the patient phenotype, phenotype-characteristic average mortality and personal survival estimate.